BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33900583)

  • 1. Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.
    Mori N; Abe H; Mugikura S; Miyashita M; Mori Y; Oguma Y; Hirasawa M; Sato S; Takase K
    Breast Cancer; 2021 Sep; 28(5):1141-1153. PubMed ID: 33900583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging.
    Miceli R; Gao Y; Qian K; Heller SL
    AJR Am J Roentgenol; 2023 Jul; 221(1):34-43. PubMed ID: 36752370
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultrafast MRI and T1 and T2 Radiomics for Predicting Invasive Components in Ductal Carcinoma in Situ Diagnosed With Percutaneous Needle Biopsy.
    Kim MY; Yoen H; Ji H; Park SJ; Kim SM; Han W; Cho N
    Korean J Radiol; 2023 Dec; 24(12):1190-1199. PubMed ID: 38016679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Lehman CD; Oseni TO; Bahl M
    Acad Radiol; 2020 Oct; 27(10):1394-1399. PubMed ID: 31699638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
    Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
    Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-aided heterogeneity analysis in breast MR imaging assessment of ductal carcinoma in situ: Correlating histologic grade and receptor status.
    Chou SS; Gombos EC; Chikarmane SA; Giess CS; Jayender J
    J Magn Reson Imaging; 2017 Dec; 46(6):1748-1759. PubMed ID: 28371110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
    Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
    Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
    Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
    Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ.
    Yoon GY; Choi WJ; Cha JH; Shin HJ; Chae EY; Kim HH
    BMC Med Imaging; 2020 Aug; 20(1):95. PubMed ID: 32787871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
    Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
    Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of ultrafast MRI evaluation for predicting histologic upgrade of ductal carcinoma in situ.
    Heo S; Park AY; Jung HK; Ko KH; Kim Y; Koh J
    Eur J Radiol; 2021 Mar; 136():109519. PubMed ID: 33429208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Performance of Radiomic Features Extracted from Breast MR Imaging in Postoperative Upgrading of Ductal Carcinoma in Situ to Invasive Carcinoma.
    Satake H; Kinoshita F; Ishigaki S; Kato K; Jo Y; Shimada S; Masuda N; Naganawa S
    Magn Reson Med Sci; 2024 May; ():. PubMed ID: 38749758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up.
    Okamoto S; Chen ST; Covelli JD; DeMartini WB; Daniel BL; Ikeda DM
    Breast Cancer; 2020 May; 27(3):405-414. PubMed ID: 31838725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
    Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
    Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
    Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
    Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Kim G; Oseni TO; Bahl M
    Acad Radiol; 2021 Mar; 28(3):e71-e76. PubMed ID: 32222328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the histologic upgrade of ductal carcinoma
    Lee HJ; Park JH; Nguyen AT; Do LN; Park MH; Lee JS; Park I; Lim HS
    Front Oncol; 2022; 12():1032809. PubMed ID: 36408141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.
    Rahbar H; Partridge SC; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
    Radiology; 2012 May; 263(2):374-82. PubMed ID: 22517955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.